New US modeling study results find nirsevimab would avert the most infant RSV-LRTD events and hospitalizations compared with clesrovimab or RSVpreF maternal vaccination. Nirsevimab provided the ...
National CPS data from 2012-2023 show declines in confirmed child maltreatment, but disparities remained, particularly among Black and female children. Confirmed child maltreatment declined, but ...
FDA grants Breakthrough Device Designation to GeneDx genome and exome tests supporting diagnosis of life-threatening genetic disorders. The FDA has granted Breakthrough Device Designation to GeneDx’s ...
FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...
New one-year data showed that baricitinib continued scalp, eyebrow, and eyelash regrowth in adolescents with severe alopecia areata. One-year data from BRAVE-AA-PEDS confirm baricitinib’s robust and ...
Newborn guidance emphasizes preparation, team training, and extended delayed cord clamping. The guidelines include new and revised recommendations across pediatric basic and advanced life support and ...
IDSA’s new GAS pharyngitis guidance emphasizes selective testing using clinical scoring to reduce overtreatment and antibiotic misuse. The update aims to reduce unnecessary antibiotic use and improve ...
The FDA has authorized Essilor Stellest eyeglass lenses to correct myopia and slow progression in children, offering a lower-risk option than contacts. The FDA has authorized the marketing of Essilor ...
The Committee voted against a proposed recommendation that "state and local jurisdictions should require a prescription for the administration of a COVID-19 vaccination.
The baby had mild respiratory distress after delivery and briefly required supplemental blow-by oxygen during transitioning. A 21-year-old primigravida woman presented to the hospital in preterm labor ...
New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year. Vaccination coverage among kindergartners in the United States declined ...
Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback